The stool-based test picks up colorectal cancers despite prior polypectomy, but many do not receive the recommended ...
Across all ages, ADC incidence did not significantly vary, whereas NEN rates rose from 2004 to 2013, increasing between 10.1% (95% CI, 4.0%-16.5%) and 12.6% (95% CI, 7.2%-18.2%) per year before ...
Interval fecal immunochemical testing was positive in up to 17% of patients after colonoscopy regardless of polypectomy, ...
An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect ...
BERLIN — Pairing a screening or surveillance colonoscopy with a same-day esophagogastroduodenoscopy (EGD) proved feasible and yielded clinically relevant upper gastrointestinal (GI) findings, ...
"In Italy, every 25 minutes we have a death from colorectal cancer, one of the 'big killers' in oncology if not diagnosed in time. Improving the very poor state of adherence to ...
Q3 2025 Earnings Call October 28, 2025 8:00 AM EDTCompany ParticipantsAlexis SmithWilliam Meury - CEO, President ...
The field of oncology has been profoundly impacted by malignant solid tumours, representing a significant challenge in healthcare. While strides have been ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Biomarker testing is ushering in a novel era of therapy personalisation for gastroesophageal and colorectal cancers, ...
Members of the Pennsylvania House overwhelmingly voted Wednesday in support of a bill proposing to reduce the age when ...
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback